ES352866A1 - Un procedimiento para la preparacion de un compuesto sele- ccionado de las 3-(omega-aminoalcohil)-1,3-benzoxazina-2- onas. - Google Patents

Un procedimiento para la preparacion de un compuesto sele- ccionado de las 3-(omega-aminoalcohil)-1,3-benzoxazina-2- onas.

Info

Publication number
ES352866A1
ES352866A1 ES352866A ES352866A ES352866A1 ES 352866 A1 ES352866 A1 ES 352866A1 ES 352866 A ES352866 A ES 352866A ES 352866 A ES352866 A ES 352866A ES 352866 A1 ES352866 A1 ES 352866A1
Authority
ES
Spain
Prior art keywords
alkyl
substituted
amino
benzoxazine
aminoalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES352866A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AH Robins Co Inc
Original Assignee
AH Robins Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AH Robins Co Inc filed Critical AH Robins Co Inc
Publication of ES352866A1 publication Critical patent/ES352866A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES352866A 1967-05-22 1968-04-18 Un procedimiento para la preparacion de un compuesto sele- ccionado de las 3-(omega-aminoalcohil)-1,3-benzoxazina-2- onas. Expired ES352866A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64038267A 1967-05-22 1967-05-22

Publications (1)

Publication Number Publication Date
ES352866A1 true ES352866A1 (es) 1970-01-16

Family

ID=24568020

Family Applications (1)

Application Number Title Priority Date Filing Date
ES352866A Expired ES352866A1 (es) 1967-05-22 1968-04-18 Un procedimiento para la preparacion de un compuesto sele- ccionado de las 3-(omega-aminoalcohil)-1,3-benzoxazina-2- onas.

Country Status (10)

Country Link
US (1) US3513166A (es)
AT (1) AT280308B (es)
CH (1) CH518964A (es)
DE (1) DE1770466A1 (es)
ES (1) ES352866A1 (es)
FR (2) FR1587057A (es)
GB (1) GB1180337A (es)
IL (1) IL29742A (es)
NL (1) NL6807248A (es)
SE (1) SE328580B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755327A (en) * 1967-06-05 1973-08-28 Fujisawa Pharmaceutical Co 1(homo)piperazinyl carbonyl alkyl 2(3h) benzimidozalinones and 2(3h) benzothiozolinone
US4074050A (en) * 1974-07-08 1978-02-14 Hodogaya Chemical Co., Ltd. Diphenyl-1,3-benzoxazine-2-ones
US4344945A (en) * 1980-03-10 1982-08-17 Kyowa Hakko Kogyo Co., Ltd. Piperidine derivatives
IT1244472B (it) * 1990-12-14 1994-07-15 Italfarmaco Spa Benzossazinoni e benzotiazinoni ad attivita' cardiovascolare
US5932726A (en) * 1996-12-16 1999-08-03 Dupont Pharmaceuticals Company Asymmetric synthesis of benzoxazinones
DE10031391A1 (de) * 2000-07-03 2002-02-07 Knoll Ag Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3019262A (en) * 1956-01-09 1962-01-30 Firestone Tire & Rubber Co Nu-benzyl-n'-phenyl-p-phenylenediamine and its manufacture
US3013020A (en) * 1958-01-24 1961-12-12 Miles Lab N,n'-bis-phenyl-alkylene-diamines
US3143572A (en) * 1959-10-08 1964-08-04 Sterling Drug Inc Nu, nu'-disubstituted-bis (aminomethyl) benzenes
CH442306A (de) * 1962-09-26 1967-08-31 Merck Ag E Verfahren zur Herstellung von 3,4-Dihydro-benzoxazinonen-(1,3,2)

Also Published As

Publication number Publication date
US3513166A (en) 1970-05-19
IL29742A (en) 1971-12-29
SE328580B (es) 1970-09-21
IL29742A0 (en) 1968-06-20
DE1770466A1 (de) 1971-10-14
NL6807248A (es) 1968-11-25
FR7755M (es) 1970-03-16
GB1180337A (en) 1970-02-04
CH518964A (de) 1972-02-15
AT280308B (de) 1970-04-10
FR1587057A (es) 1970-03-13

Similar Documents

Publication Publication Date Title
LU90014I2 (fr) Invirase ou un de ses dérivés ou sels pharmaceutiquement acceptables Saquinavir
SE8700499D0 (sv) Novel pharmacologically active compounds
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
FI96204C (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
ATE108437T1 (de) Substituierte diaminophthalimide und analoga.
ES352866A1 (es) Un procedimiento para la preparacion de un compuesto sele- ccionado de las 3-(omega-aminoalcohil)-1,3-benzoxazina-2- onas.
ES8403910A1 (es) Procedimiento para la preparacion de nitratos de amino-deso-xi-1.4;3.6-dianhidro-hexito,asi como de sus sales de adicionacida farmacologicamente inocuas
NO960632D0 (no) Nye bis-naftalimider for behandling av kreft
GB1381184A (en) Sulphamides
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
GB1220447A (en) Salicylic acid derivatives
NO873722L (no) Nye derivater av 4,5-dihydro-oksazoler, samt fremgangsmaate for deres fremstilling.
GB1502873A (en) Pharmaceutical compositions with ulcer healing activity
NZ220195A (en) 2-pyridyl-penem derivatives and pharmaceutical compositions
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
ES455791A1 (es) Procedimiento para preparar derivados de tetrahidro-equino- candina b.
GB1106592A (en) New asymmetrically di-n-substituted piperazines and process for their manufacture
GB902659A (en) A process for the production of a derivative of thebaine
ES499915A1 (es) Procedimiento para la obtencion de derivados del aminotia- diazolilo
ES348433A1 (es) Procedimiento de preparacion de nuevos derivados de la di- benzo (c,f) tiazepina (1,2).
ES433080A1 (es) Procedimiento de produccion de un compuesto espiro.
ES345993A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
ES345690A1 (es) Procedimiento para la preparacion de 2-aminometil-benzofu- ranos sustituidos.
GB1143061A (en) Improvements in or relating to compositions affecting learning and retention
GB1176049A (en) N-Substituted Noratropinium Salts